CD47 and glioblastoma: In addition to that, while CD47 is better known for immune evasion, recent studies suggest its role in the malignant metabolic switch towards glycolysis in the GBM TME, suggesting that blocking CD47 may enhance microglia-mediated cytotoxicity against GBM [186].